The use of long-acting injectables in early-phase schizophrenia 

被引：0
|
作者：
Tiihonen, Jari [1 ,2 ,3 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Stockholm Hlth Care Serv, Ctr Psychiat Res, Stockholm, Region Stockhol, Sweden
[3] Univ Eastern Finland, Niuvanniemi Hosp, Dept Forens Psychiat, Kuopio, Finland
来源：
LANCET PSYCHIATRY | 2023年 / 10卷 / 07期
关键词：
D O I：
10.1016/S2215-0366(23)00141-4
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：481 / 482
页数：2
相关论文
共 50 条
  • [1] The use of long-acting injectables in early-phase schizophrenia Reply
    Fleischhacker, W. Wolfgang
    Rossum, Inge Winter-van
    Kahn, Rene S.
    LANCET PSYCHIATRY, 2023, 10 (07): : 482 - 483
  • [2] The relevance of long-acting injectables in the treatment of schizophrenia
    Hahn, Martina
    Roll, Sibylle Christine
    LANCET PSYCHIATRY, 2023, 10 (03): : 159 - 160
  • [3] ADDRESSING SYSTEMIC BARRIERS FOR THE USE OF LONG-ACTING INJECTABLES IN EARLY PSYCHOSIS
    Wadell, Paula
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S44 - S44
  • [4] Improving Outcomes in Schizophrenia-A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness
    Gouse, Brittany M.
    Brown, Hannah E.
    JAMA NETWORK OPEN, 2022, 5 (07)
  • [5] Short-acting antipsychotics or long-acting injectables? A treatment comparison in patients with schizophrenia
    Thiem, Helena
    Folkerts, Here
    Voelkel, Lukas
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2020, 25 (03): : 170 - 178
  • [6] Effectiveness of oral versus long-acting antipsychotic treatment early-phase schizophrenia patients: an openlabel randomized trial
    Winter, I.
    Davidson, M.
    Fleischhacker, W.
    Kahn, R.
    EUROPEAN PSYCHIATRY, 2022, 65 : S130 - S130
  • [7] Importance of preventing relapse - benefits and place of long-acting injectables in treatment of schizophrenia
    Taylor, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S758 - S758
  • [8] Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia
    Rubio, Jose M.
    Mychaskiw, Marko A.
    Lim, Sangtaeck
    Suett, Mark
    Wang, Yitong
    Tian, Marc
    Kane, John M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (02)
  • [9] What role do long-acting injectables (LAIs) have in the treatment of schizophrenia?
    Schreiner, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S632 - S632
  • [10] Equity in access to long-acting injectables in the USA
    Hojilla, J. Carlo
    Gandhi, Monica
    Satre, Derek D.
    Johnson, Mallory O.
    Saberi, Parya
    LANCET HIV, 2022, 9 (03): : E145 - E147
12345